Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-07T23:25:52.740Z Has data issue: false hasContentIssue false

14 - Leukemia during pregnancy

from Part II - Specific tumors during pregnancy

Published online by Cambridge University Press:  06 July 2010

G. Koren
Affiliation:
The Hospital for Sick Children, Toronto
M. Lishner
Affiliation:
University of Toronto
Get access

Summary

The information regarding leukemia complicating pregnancy is very limited. Since there is no systematic registration of leukemia in pregnancy, the existing knowledge is based mainly on retrospective analyses or case reports. These reports tend to describe unusual or successful cases. Thus, review articles of the published experience may have perpetuated a reporting bias. Leukemia occurring during pregnancy is very rare with an estimated incidence of one per 100000 pregnancies annually. This figure is about 3.5 times lower than the incidence of leukemia in the general population in the Western world. This lower incidence may be explained by the fact that most acute lymphatic leukemias occur in childhood, while most acute myeloid leukemias occur in late adulthood, thus relatively sparing the child-bearing years. Chronic myeloid leukemia is the main chronic leukemia during pregnancy, since chronic lymphocytic leukemia is founded mainly in the elderly.

It had been estimated that, during pregnancy, acute leukemias are more frequent than chronic and that myeloid leukemias are detected twice as often as lymphatic leukemias. The appearance of leukemia during the first trimester of pregnancy is least common, and may be explained by the use of therapeutic abortion in patients diagnosed in this trimester.

The survival of pregnant and nonpregnant leukemic women has improved with the availability of modern chemotherapy and supportive care. Remission rates of 70–75% and median survival time of 6–12 months are currently reported for pregnant women. These figures are not different from those achieved in young nonpregnant women with acute leukemia.

Type
Chapter
Information
Cancer in Pregnancy
Maternal and Fetal Risks
, pp. 143 - 146
Publisher: Cambridge University Press
Print publication year: 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×